Pulse Biosciences, Inc.
PLSE
Revenue
0.00
0.000.00%
3 Months ChangeAssets
93.05M
▲52.62M▲130.15%
3 Months ChangeLiabilities
13.92M
▲456.00k▲3.39%
3 Months ChangeFree Cash Flow
-9.79M
▼-3.18M▼-48.06%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-10-31
Form 8-K
ID: 0001437749-24-032770
2024-10-30
Form 10-Q
ID: 0001437749-24-032614
2024-10-30
Form 8-K
ID: 0001437749-24-032613
2024-08-19
Form 10-Q
ID: 0001437749-24-027213
2024-08-12
Form 8-K
ID: 0001437749-24-026104
2024-08-12
Form 8-K
ID: 0001437749-24-026060
2024-08-08
Form 8-K
ID: 0001437749-24-025296
2024-07-15
Form 8-K
ID: 0001193125-24-178827
2024-07-08
Form 8-K
ID: 0001437749-24-022297
2024-07-03
Form 8-K
ID: 0001437749-24-022162